758 related articles for article (PubMed ID: 28035075)
1. The Hippo signaling pathway provides novel anti-cancer drug targets.
Bae JS; Kim SM; Lee H
Oncotarget; 2017 Feb; 8(9):16084-16098. PubMed ID: 28035075
[TBL] [Abstract][Full Text] [Related]
2. Targeting the Hippo Signaling Pathway for Tissue Regeneration and Cancer Therapy.
Juan WC; Hong W
Genes (Basel); 2016 Aug; 7(9):. PubMed ID: 27589805
[TBL] [Abstract][Full Text] [Related]
3. The biology of YAP/TAZ: hippo signaling and beyond.
Piccolo S; Dupont S; Cordenonsi M
Physiol Rev; 2014 Oct; 94(4):1287-312. PubMed ID: 25287865
[TBL] [Abstract][Full Text] [Related]
4. Targeting the Hippo Pathway for Anti-cancer Therapies.
Gong R; Yu FX
Curr Med Chem; 2015; 22(35):4104-17. PubMed ID: 26429069
[TBL] [Abstract][Full Text] [Related]
5. Role of the Hippo pathway and mechanisms for controlling cellular localization of YAP/TAZ.
Kwon H; Kim J; Jho EH
FEBS J; 2022 Oct; 289(19):5798-5818. PubMed ID: 34173335
[TBL] [Abstract][Full Text] [Related]
6. YAP/TAZ Signaling as a Molecular Link between Fibrosis and Cancer.
Noguchi S; Saito A; Nagase T
Int J Mol Sci; 2018 Nov; 19(11):. PubMed ID: 30463366
[TBL] [Abstract][Full Text] [Related]
7. The Hippo pathway effectors TAZ and YAP in development, homeostasis and disease.
Varelas X
Development; 2014 Apr; 141(8):1614-26. PubMed ID: 24715453
[TBL] [Abstract][Full Text] [Related]
8. Molecular mechanisms of the mammalian Hippo signaling pathway.
Ji XY; Zhong G; Zhao B
Yi Chuan; 2017 Jul; 39(7):546-567. PubMed ID: 28757470
[TBL] [Abstract][Full Text] [Related]
9. YAP and TAZ Take Center Stage in Cancer.
Zhang K; Qi HX; Hu ZM; Chang YN; Shi ZM; Han XH; Han YW; Zhang RX; Zhang Z; Chen T; Hong W
Biochemistry; 2015 Nov; 54(43):6555-66. PubMed ID: 26465056
[TBL] [Abstract][Full Text] [Related]
10. An evaluation of TAZ and YAP crosstalk with TGFβ signalling in canine osteosarcoma suggests involvement of hippo signalling in disease progression.
Luu AK; Schott CR; Jones R; Poon AC; Golding B; Hamed R; Deheshi B; Mutsaers A; Wood GA; Viloria-Petit AM
BMC Vet Res; 2018 Nov; 14(1):365. PubMed ID: 30477496
[TBL] [Abstract][Full Text] [Related]
11. YAP/TAZ: a promising target for squamous cell carcinoma treatment.
Dong X; Meng L; Liu P; Ji R; Su X; Xin Y; Jiang X
Cancer Manag Res; 2019; 11():6245-6252. PubMed ID: 31360073
[TBL] [Abstract][Full Text] [Related]
12. Hippo pathway - brief overview of its relevance in cancer.
Zygulska AL; Krzemieniecki K; Pierzchalski P
J Physiol Pharmacol; 2017 Jun; 68(3):311-335. PubMed ID: 28820389
[TBL] [Abstract][Full Text] [Related]
13. Identification of PTPN12 Phosphatase as a Novel Negative Regulator of Hippo Pathway Effectors YAP/TAZ in Breast Cancer.
Sarmasti Emami S; Ge A; Zhang D; Hao Y; Ling M; Rubino R; Nicol CJB; Wang W; Yang X
Int J Mol Sci; 2024 Apr; 25(7):. PubMed ID: 38612874
[TBL] [Abstract][Full Text] [Related]
14. YAP and TAZ: a nexus for Hippo signaling and beyond.
Hansen CG; Moroishi T; Guan KL
Trends Cell Biol; 2015 Sep; 25(9):499-513. PubMed ID: 26045258
[TBL] [Abstract][Full Text] [Related]
15. A Computational Model of YAP/TAZ Mechanosensing.
Sun M; Spill F; Zaman MH
Biophys J; 2016 Jun; 110(11):2540-2550. PubMed ID: 27276271
[TBL] [Abstract][Full Text] [Related]
16. Mechanoregulation and pathology of YAP/TAZ via Hippo and non-Hippo mechanisms.
Dobrokhotov O; Samsonov M; Sokabe M; Hirata H
Clin Transl Med; 2018 Aug; 7(1):23. PubMed ID: 30101371
[TBL] [Abstract][Full Text] [Related]
17. The role of YAP/TAZ activity in cancer metabolic reprogramming.
Zhang X; Zhao H; Li Y; Xia D; Yang L; Ma Y; Li H
Mol Cancer; 2018 Sep; 17(1):134. PubMed ID: 30176928
[TBL] [Abstract][Full Text] [Related]
18. GPCR-Hippo Signaling in Cancer.
Luo J; Yu FX
Cells; 2019 May; 8(5):. PubMed ID: 31072060
[TBL] [Abstract][Full Text] [Related]
19. Geranylgeranylation signals to the Hippo pathway for breast cancer cell proliferation and migration.
Mi W; Lin Q; Childress C; Sudol M; Robishaw J; Berlot CH; Shabahang M; Yang W
Oncogene; 2015 Jun; 34(24):3095-106. PubMed ID: 25109332
[TBL] [Abstract][Full Text] [Related]
20. The transcriptional regulators TAZ and YAP direct transforming growth factor β-induced tumorigenic phenotypes in breast cancer cells.
Hiemer SE; Szymaniak AD; Varelas X
J Biol Chem; 2014 May; 289(19):13461-74. PubMed ID: 24648515
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
